Shanghai VKEY Biotechnologies Co.,Ltd.
Shanghai VKEY Biotechnologies Co.,Ltd.
Email Us

KeyTec® TR-FRET Hybridoma screening kit (Biotinylated antigen, Mouse IgG)

Quick replication of product information

KeyTec® TR-FRET Hybridoma screening kit (Biotinylated antigen, Mouse IgG)

Size:

Price: $ 1824

CAT.: A1040006S

A1040006S_1.1.jpg
A1040006S_1.1.jpg
A1040006S_1.1.jpg
A1040006S_1.1.jpg
A1040006S_1.1.jpg
A1040006S_1.1.jpg

Size:
1,000 tests
10,000 tests
Price:
$ 1824
CAT.:
A1040006S
Delivery:
Available in Stock
Price:
$ 12100
CAT.:
A1040006L
Delivery:
Available in Stock
KeyTec® TR-FRET Hybridoma screening kit (Biotinylated antigen, Mouse IgG)
1,000 tests
1,000 tests
10,000 tests
CAT.: A1040006S
$ 1824 $ 12100
Overview
Performance
Protocols
Components
Notices
Related Products

Overview

The KeyTec® TR-FRET Hybridoma screening kit (Biotinylated antigen, Mouse IgG) is designed for the simple and rapid screening of positive mouse hybridoma clones based on antigen-antibody affinity in cell supernatant. It is based on sandwich immunoassay model and utilizes TR-FRET technology, known for its ease of use, homogeneity (no wash), low background, high sensitivity, robustness.
The screening principle is based on TR-FRET technology. The Streptavidin-Solar Eu binds to the Biotinylated antigen, while the pAb anti-Mouse Fc-LA binds to the mouse Fc of IgG antibodies expressed by mouse hybridoma. When the antigen-antibody interact, the donor molecule is brought into proximity with the acceptor molecule. Excitation of the donor will result in the generation of the TR-FRET signal at 665 nm, proportional to the extent of protein interaction.
EN_A1040006S_2.1.png

Performance

A1040006S_3.1.png
• Optimization of Antigen and Antibody Concentration
• Range of Antibody concentration: 100 ng/mL – 80 µg/mL*5
• Incubation Condition:Incubate at room temperature for 1 hours to overnight
A1040006S_3.2.png
• Effects of various matrices

Protocols

Components

CAT. Description Size
A1040006S KeyTec® TR-FRET Hybridoma screening kit (Biotinylated antigen, Mouse IgG) 1,000 tests
The tests are sufficient in a 384-well microplate assay format, with 20 μL per well.
• 1 × 100 µL Streptavidin - Solar Eu (50X)
• 1 × 100 µL pAb anti-Mouse Fc - LA (50X)
• 1 × 40 mL Hybridoma Detection Buffer
• 1 × Positive Control (1X),Lyophilized

Notices

Certificate of Analysis Limitations Storage Conditions
LOT. For research use only -60℃ or below

-60℃ or below

Overview

The KeyTec® TR-FRET Hybridoma screening kit (Biotinylated antigen, Mouse IgG) is designed for the simple and rapid screening of positive mouse hybridoma clones based on antigen-antibody affinity in cell supernatant. It is based on sandwich immunoassay model and utilizes TR-FRET technology, known for its ease of use, homogeneity (no wash), low background, high sensitivity, robustness.
The screening principle is based on TR-FRET technology. The Streptavidin-Solar Eu binds to the Biotinylated antigen, while the pAb anti-Mouse Fc-LA binds to the mouse Fc of IgG antibodies expressed by mouse hybridoma. When the antigen-antibody interact, the donor molecule is brought into proximity with the acceptor molecule. Excitation of the donor will result in the generation of the TR-FRET signal at 665 nm, proportional to the extent of protein interaction.
EN_A1040006S_2.1.png

Performance

A1040006S_3.1.png
• Optimization of Antigen and Antibody Concentration
• Range of Antibody concentration: 100 ng/mL – 80 µg/mL*5
• Incubation Condition:Incubate at room temperature for 1 hours to overnight
A1040006S_3.2.png
• Effects of various matrices

Protocols

Components

CAT. Description Size
A1040006L KeyTec® TR-FRET Hybridoma screening kit (Biotinylated antigen, Mouse IgG) 10,000 tests
The tests are sufficient in a 384-well microplate assay format, with 20 μL per well.
• 1 × 1 mL Streptavidin - Solar Eu (50X)
• 1 × 1 mL pAb anti-Mouse Fc - LA (50X)
• 1 × 200 mL Hybridoma Detection Buffer
• 2 × Positive Control (1X),Lyophilized

Notices

Certificate of Analysis Limitations Storage Conditions
LOT. For research use only -60℃ or below

-60℃ or below

Related Biotherapeutics